Ignite Creation Date:
2025-12-24 @ 10:31 PM
Ignite Modification Date:
2026-05-29 @ 12:11 PM
Study NCT ID:
NCT00023335
Status:
COMPLETED
Last Update Posted:
2005-09-05
First Post:
2001-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis
Sponsor:
Centers for Disease Control and Prevention
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Pulmonary Tuberculosis | View |
Keywords: